Centre Hospitalier Annecy Genevois — Clinical Trial Site

129 Registered trials

53 Currently recruiting

Organisation

Centre Hospitalier Annecy Genevois

Location

Pringy Cedex, France

Identifier

ORG-100013449

Address

1 Avenue De L Hopital, Bp 90074, 74370, France

Departments

-
0450636030
Anesthésie- Réanimation
Cancérologie - Oncologie
Cardiology
Centre d’Etude et de Traitement de la Douleur A1
Chirurgie digestive
Clinical Hematology
Département de Cardiologie
Departement of Dermatology
dermatologie
Dermatology
Douleurs et Céphalées - Centre d'Etude et de Traitement de la Douleur A1
Endocrinologie
FR10022: Hematology
gastro enterology
Gastroenterologie
gastroenterology
Haematology
HEMATOLOGIE
Hématologie Clinique
Hématologie Oncologie
Hematology
Hematology Department
Hépato Gastro Entérologie
Hepato gastro enterology
Hépato-gastroentérologie
Hepatogastroenterology
HGE
Infectiologie
Infectiologie, médecine interne et médecine des voyages
Infectious Diseases
Internal Medicine
Maladies Infectieuses
Maladies Infectieuses et Médecine Interne
Maladies Infectieuses et Tropicales
Médecine Interne
Medical Oncology
Medical Oncology Department
N/A
NA
Néphrologie
Nephrology Department
Obstetrics
Oncologie
Oncologie Médicale
Oncology
oncology department
ORL
Pneumologie
Pneumology
Radiothérapie
Réanimation
Savoie
Service d'Hématologie
Service d'hématologie clinique
Service d'Hepato-gastro-enterologie
Service d'Oncologie
Service d’Hématologie
Service d’Hepato-gastro-enterologie et endoscopies
Service d’Infectiologie et de Médecine Interne
Service de Pneumologie
Site d'Annecy
SMUR
Unité de soin intensif

Clinical trials at this site (129)

Search interface

PRODIGE 98- AMPIRINOX : Randomized, multicenter, Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or ge… Recruiting

2024-511070-68-01 Ampullary adenocarcinoma 5 2024-09-24
FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage Recruiting

2024-515118-42-00 Colorectal cancer 11 2024-09-10
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
FIRST-NEC - A multicenter phase II study evaluating the efficacy and safety of the combination of durvalumab (MEDI 4736) with etoposide and … Recruiting

2023-506590-35-00 Large-Cell NeuroEndocrine Carcinoma of the lung 4 2024-06-13
MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal a… Recruiting

2023-505436-35-00 Untreated FLIPI 2-5 Follicular Lymphoma 5 2024-06-03
Evaluation of EXL01 a new Live Biotherapeutic Product to prevent recurrence of Clostridioides difficile infection in high-risk patients. LIV… Recruiting

2023-506232-32-00 Multiple recurrences of Clostridioides difficile infect 9 2024-04-08
Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute Recruiting

2022-502974-18-00 C. spp. prosthetic joint infection 10 2023-11-27
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Catheter related bloodstream infections due to Staphylo 5 2023-06-23
Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting

2022-501710-62-02 Peripheral T-cell lymphoma (PTCL) 6 2023-06-07
TRAK-ER_A randomised trial of early detection of molecular relapse with circulating tumour DNA tracking and treatment with palbociclib plus … Recruiting

2024-517414-15-00 ER positive HER2 negative breast cancer 4 2023-01-25
Baricitinib in patients with relapsing or naïve dermatomyositis (BIRD) Recruiting

2024-511899-32-00 Dermatomyositis; Baricitinib in patients with relapsing 10 2022-08-31
Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting

2022-502425-18-00 Adenocarcinoma of the prostate 5 2022-04-19
Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting

2024-511609-44-00 Rectum cancer 10 2022-02-03
IFM2020-05-BENEFIT-Multicenter Open label Phase 3 study of Isatuximab plus Lenalidomide and Dexamethasone with/without Bortezomib in the Tre… Recruiting

2024-517215-67-00 Newly diagnosed Non-Frail transplant Ineligible Multipl 5 2021-06-11
Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting

2024-513427-17-00 Well controlled severe allergic asthma 6 2021-05-20
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for… Recruiting

2024-511904-18-00 Pancreatic adenocarcinoma (PAC) 10 2020-07-08
Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 Advanced tumors 5 2018-08-24
CLAZI : CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective co… Recruiting

2024-518578-15-00 Is to demonstrate a non inferior efficacy of azithromyc 5 2018-02-05
GRAALL2014 Recruiting

2024-516103-16-00 Acute Lymphoblastic Leukemia (ALL) in younger adults (1 4 2015-12-04
PEHRICCA : PErioperative CISGEM plus RILVEGOSTOMIG in High-Risk resectable Intrahepatic CholangioCarcinoma Ended

2025-521302-17-00 Hihg risk of cholangiocarcinoma intra hépatic resectabl 10 2026-05-26
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
Phase 2/3 Randomized Study of INBRX-106 Add-on to Pembrolizumab in First-Line PD-L1 CPS ≥20 R/M HNSCC (HexAgon-HN) Ended

2024-515538-34-00 Head and Neck Squamous Cell Carcinoma 10 2025-02-27
Management of Anticoagulant Therapy monitored by an implantable device with telecardiology in patients with Acute Coronary Syndrome associat… Ended

2024-515433-15-02 acute coronary syndrome 6 2025-01-29